#Chimerix Inc (CMRX) - Prohost Biotech

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

Jazz Pharmaceuticals to Acquire Chimerix Today, March 5, 2025, Jazz Pharmaceuticals ( JAZZ ) and Chimerix ( CMRX ) announced the companies have entered into a definitive agreement for Jazz to acquire...

P

Prohost Biotech

Mar 5, 2025

Prohost Letter #392

Prohost Letter #392 February 28, 2016 - How could it be possible for any genius to make intelligent guesses about the market's next moves when highly regarded experts, including Nobel Prize winners i...

P

Prohost Biotech

Feb 29, 2016

Prohost Letter #385

Prohost Letter #385 An Evaluation of Prohost Picks and Some Other Interesting Biotechnology Companies The Top-Tier Group The indiscriminate attack on the biotech sector impacted the best biotech firms...

P

Prohost Biotech

Oct 21, 2015

Prohost Letter #384

Prohost Letter #384 The Assassination of the Biotech Sector The Market (Part 2) On Friday September 18, 2015, the biotechnology sector occupied the news headlines for two different reasons. The first...

P

Prohost Biotech

Oct 6, 2015

Prohost Letter #383

Prohost Letter #383 The Market - Recent tails about the market and the biotech sector are true thrillers. By true we mean no-fiction. The accounts lack common sense. Professionals' interpretations of...

P

Prohost Biotech

Sep 25, 2015

Portola Is on the Right Track

Portola Pharmaceuticals (PTLA) announced that the second part of its Phase 3 ANNEXA ™ -R (Andexanet Alfa a Novel Antidote to the Anticoagulant Effects of FXa Inhibitors -- Rivaroxaban ) study achieved...

P

Prohost Biotech

Sep 15, 2015

Time to Talk About Great Expectations?

Time to talk about the expectations and the opportunities? We believe there is always time for serious evidence-based facts. Exelixis The U.S. Food & Drug Administration’s (FDA) granting Breakthroug...

P

Prohost Biotech

Aug 25, 2015

Prohost Letter #380

Prohost Letter #380 Investors Concerns, Excitments and Expectations PART 2 REGENERON On Friday, July 24, Regeneron (REGN) stock closed at $541.l85 DOWN $14.76. The reason for loss was good news annou...

P

Prohost Biotech

Jul 27, 2015

WOW! Eight Prohost Picks Hit 52 Weeks High and All-Time High! Excellent News from Exelixis Too

What A Week For Prohost Portfolios During the past week, a large number of firms in our Portfolios hit 52-weeks high, with some hitting all-time high. These biotech firms include: Illumina (ILMN) Rege...

P

Prohost Biotech

Jul 20, 2015

Angry Market Versus Optimistic Investors

An Angry Market When the market gets angry it loses its sight and insight. Its tools for fair evaluation look as if the Stock market has acquired a mutation in its gene responsible for the accuracy...

P

Prohost Biotech

Jun 26, 2015

Prohost Portfolio Stocks Escaping Friday Intended Selloff

Although still a profit taking day, some of the following firms rallied, others did well and some escaped the selloff. Stocks That Escaped Friday’s Profit Taking AMGN: The stock remained positive, clo...

P

Prohost Biotech

Jun 19, 2015

Chimerix Is a Great Firm. Amgen and Regenreon Cholesterol Lowering Drugs Will Be Blockbusters

Do not be afraid that something might have gone wrong with Chimerix (CMRX) as the stock has given away a little more than 3% of its value in early Wednesday’s morning. No bad news has emerged from any...

P

Prohost Biotech

Jun 11, 2015

Prohost Letter #378 Part 2

Prohost Letter #378 Part 2 2015 ASCO ANNUAL MEETING What a Big Revolution in Oncology! The ASCO meeting projected the huge advancement in the understanding, diagnosing and treating cancer. What looked...

P

Prohost Biotech

Jun 9, 2015

Today: Vertex and the Experts' Panel

WE HEARD While dumping a lot of immaterial news we believe is meaningless to the clinic, we are highlighting other news coming from the accomplishing biotech firms. We will also analyze and evaluate t...

P

Prohost Biotech

May 12, 2015

Looking Forward and Some Good News in a Bad Market Day

WHAT INVESTORS ARE LOOKING FORWARD TO HEAR? 1. Incyte’s (INCY) i nvestor meeting, which will be webcast live, at 7:00 p.m. EDT on April 20, 2015. The event will discuss the data, science and strategy...

P

Prohost Biotech

Apr 17, 2015

Prohost Outperformers Today

From Prohost Elite Group VRTX CLOSED AT $120.34 UP $2.74 2.33% ILMN CLOSED AT $187.17 UP $2.80 1.52% REGN CLOSED...

P

Prohost Biotech

Mar 27, 2015

An Approval and Works in Progress. See Also: Fishing for Undervalued Biotech Stocks

Approval Of Anthrax Therapeutic Emergent BioSolutions (EBS) : The FDA has approved Anthrasil™ [Anthrax Immune Globulin Intravenous (Human)], also known as AIGIV, for inhalational anthrax in combinati...

P

Prohost Biotech

Mar 25, 2015

Our Thursday Mid-Morning Outperforming Stocks

PROHOST OUTPERFORMING STOCKS Mid-Morning of Thursday, March 19, 2015 From Prohost Elite Group REGN TRADING AT $479 UP $6.89 1.61% VRTX TRADING A...

P

Prohost Biotech

Mar 19, 2015

Prohost Outperforming Picks Closing

PROHOST OUTPERFORMING STOCKS Closing Prices March 19, 2015 From Prohost Elite Group VRTX CLOSED AT $134.25. UP $4.46 3.44% REGN CLOSED AT $486.02...

P

Prohost Biotech

Mar 19, 2015

Amgen and Regeneron Rallies. See Other Outperforming Picks

The talk of the town now is about the anti-LDL drugs Repatha developed by Amgen (AMGN) and Praluent developed by Sanofi and Regeneron (REGN) ; both are PCSK9 inhibitors, a new class of anti-lipemic dr...

P

Prohost Biotech

Mar 17, 2015

1m

4